一个小分子稳定剂拯救了GPCR中几乎所有误解变体的表面表达
Taylor L Mighell1, Ben Lehner2,3,4,5
1Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Nature structural & molecular biology
|September 22, 2025
概括
药理伴随者可以拯救由罕见的遗传变异引起的蛋白质稳定性缺陷. 这项研究证明了它们对血管压素2受体变异的广泛疗效,为原性无味糖尿病和其他罕见疾病提供了潜在的治疗策略.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 减少蛋白质丰富度是罕见遗传疾病的常见原因.
- 药理伴随剂 (PC) 是稳定蛋白质的小分子,是一种新兴的治疗策略.
- 针对不同蛋白质变体的PC的一般有效性需要进一步研究.
研究的目的:
- 建立一个框架来评估针对目标蛋白的所有致病变体的PC疗效.
- 调查PCs在拯救导致原性糖尿病无味症 (NDI) 的不稳定压素2受体 (V2R) 变体方面的潜力.
主要方法:
- 为导致NDI的V2R变体分配的分子机制.
- 测量了使用PC治疗后不稳定V2R变异的表达救援.
- 识别了使用非救援变体的PC结合点.
主要成果:
- 超过一半的NDI变异是由蛋白质稳定性丧失引起的.
- 电脑可以挽救87%不稳定的V2R变种的表达.
- 不被救出的变体有助于预测PC结合部位.
结论:
- 蛋白质稳定性的丧失是NDI变体的主要致病机制.
- 药理伴随者在拯救不稳定的V2R变种方面表现出广泛的有效性.
- 这种方法为开发PC治疗各种由蛋白质不稳定引起的罕见疾病提供了原则证明.
更多相关视频
相关概念视频
01:12GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
02:27Nonsense-mediated mRNA Decay
11.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.7K